OrgUnit's Researchers
(Persons)

Results 1-5 of 20 (Search time: 0.002 seconds).

FullnameTranslated NameEmail
Baker, AmyAmy.BAKER@austin.org.au
Balasubramanian, Adithyaadithya.balasubramanian@austin.org.au
Burgess, Adele NAdele.BURGESS@austin.org.au
Cher, Lawrence MLawrence.CHER@austin.org.au
Fancourt, TinekeTineke.FANCOURT@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 461-480 of 548 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
46130-Oct-2017SCORE: Shared care of Colorectal cancer survivors: protocol for a randomised controlled trial.Jefford, Michael; Emery, Jon; Grunfeld, Eva; Martin, Andrew; Rodger, Paula; Murray, Alexandra M; De Abreu Lourenco, Richard; Heriot, Alexander; Phipps-Nelson, Jo; Guccione, Lisa; King, Dorothy; Lisy, Karolina; Tebbutt, Niall C ; Burgess, Adele N ; Faragher, Ian; Woods, Rodney; Schofield, Penelope
4622020Sensitization of Cancers Resistant to HER2 Antibodies.Parakh, Sagun ; Gan, Hui K ; Scott, Andrew M 
46320-Aug-2023Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma.Robert, Caroline; Carlino, Matteo S; McNeil, Catriona; Ribas, Antoni; Grob, Jean-Jacques; Schachter, Jacob; Nyakas, Marta; Kee, Damien ; Petrella, Teresa M; Blaustein, Arnold; Lotem, Michal; Arance, Ana; Daud, Adil I; Hamid, Omid; Larkin, James; Anderson, James; Krepler, Clemens; Grebennik, Dmitri; Long, Georgina V
46417-Dec-2006Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus.Davey, Rachel A; Tebbutt, Niall C ; Favaloro, Jenny M; O'neal, David N; Rae, Derek; Zajac, Jeffrey D ; Best, James D
465Jun-2016Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC).Chia, Puey Ling ; John, Thomas 
4662022Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials.Ledenko, Matthew; Antwi, Samuel O; Arima, Shiho; Driscoll, Julia; Furuse, Junji; Klümpen, Heinz-Josef; Larsen, Finn Ole; Lau, David K ; Maderer, Annett; Markussen, Alice; Moehler, Markus; Nooijen, Lynn E; Shaib, Walid L; Tebbutt, Niall C ; André, Thierry; Ueno, Makoto; Woodford, Rachel; Yoo, Changhoon; Zalupski, Mark M; Patel, Tushar
4674-Nov-2013Should we screen for lung cancer in Australia?Mitchell, Paul L R ; John, Thomas 
46816-Aug-2021Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.Murali, Krithika; Dwarte, Tanya M; Nikfarjam, Mehrdad ; Tucker, Katherine M; Vaughan, Rhys B ; Efthymiou, Marios ; Collins, Allison L ; Spigelman, Allan D; Salmon, Lucinda ; Johns, Amber L; Williams, David B; Delatycki, Martin B ; John, Thomas ; Stoita, Alina
46917-Sep-2012A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.Wong, S F; Gan, Hui K ; Cher, Lawrence M 
4702022Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.Dimitriou, F; Namikawa, K; Reijers, I L M; Buchbinder, E I; Soon, J A; Zaremba, A; Teterycz, P; Mooradian, M J; Armstrong, E; Nakamura, Y; Vitale, M G; Tran, L E; Bai, X; Allayous, C; Provent-Roy, S; Indini, A; Bhave, P; Farid, M; Kähler, K C; Mehmi, I; Atkinson, V; Klein, Oliver ; Stonesifer, C J; Zaman, F; Haydon, A; Carvajal, R D; Hamid, O; Dummer, R; Hauschild, A; Carlino, M S; Mandala, M; Robert, C; Lebbe, C; Guo, J; Johnson, D B; Ascierto, P A; Shoushtari, A N; Sullivan, R J; Cybulska-Stopa, B; Rutkowski, P; Zimmer, L; Sandhu, S ; Blank, C U; Lo, S N; Menzies, A M; Long, G V
471Sep-2023Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions.Whitfield, Holly J; Berthelet, Jean; Mangiola, Stefano; Bell, Caroline; Anderson, Robin L ; Pal, Bhupinder; Yeo, Belinda ; Papenfuss, Anthony T; Merino, Delphine; Davis, Melissa J
4722021The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile.Berthelet, Jean; Wimmer, Verena C; Whitfield, Holly J; Serrano, Antonin; Boudier, Thomas; Mangiola, Stefano; Merdas, Michal; El-Saafin, Farrah; Baloyan, David; Wilcox, Jordan; Wilcox, Steven; Parslow, Adam C; Papenfuss, Anthony T; Yeo, Belinda ; Ernst, Matthias ; Pal, Bhupinder; Anderson, Robin L ; Davis, Melissa J; Rogers, Kelly L; Hollande, Frédéric; Merino, Delphine
473Sep-2021SMARTphone Based Cardiovascular Risk Reduction in BREAST Cancer Patients (SMART-BREAST): A Randomised Controlled Trial Protocol.Murphy, Alexandra C ; Farouque, Omar ; Yeo, Belinda ; Dick, Ron; Koshy, Anoop N ; Roccisano, Laura; Reid, Christopher; Raman, Jaishankar; Kearney, Leighton G ; Yudi, Matias B 
4743-Oct-2018Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis.O'Keeffe, Linda M; Taylor, Gemma; Huxley, Rachel R; Mitchell, Paul L R ; Woodward, Mark; Peters, Sanne A E
4756-Dec-2011Smoking history as a predictive factor of treatment response in advanced non-small-cell lung cancer: a systematic review.Mitchell, Paul L R ; Mok, Tony; Barraclough, Helen; Strizek, Alena; Lew, Rebecca; van Kooten, Maximiliano
476Jun-2020Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse.Leimgruber, Antoine; Hickson, Kevin; Lee, Sze Ting ; Gan, Hui K ; Cher, Lawrence M ; Sachinidis, John I; O'Keefe, Graeme J; Scott, Andrew M 
47727-Oct-2009Spinal drop metastasis from grade I skull base chondrosarcoma.Hall, Nick D P; Fabinyi, Gavin C ; Gul, Shahid M; Cher, Lawrence M ; Leibsch, Norbert J
478May-2019Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease.Arulananda, Surein; Do, Hongdo; Rivalland, Gareth; Loh, Zoe ; Musafer, Ashan; Lau, Eddie ; Mitchell, Paul; Dobrovic, Alexander ; John, Thomas 
4792-Sep-2017Standard of care in immunotherapy trials: Challenges and considerations.Rivalland, Gareth; Scott, Andrew M ; John, Thomas 
480Nov-2021Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease.McLean, Luke S; Faisal, Wasek; Parakh, Sagun ; Kao, Steven C; Lewis, Craig R; Chin, Melvin T; Voskoboynik, Mark; Itchins, Malinda J; Jennens, Ross R; Broad, Adam R; Morris, Tessa A; Solomon, Benjamin J